↗️ There has been a steady increase in #cholera cases in recent years, with multiple countries experiencing concurrent outbreaks amid short supply of cholera vaccine stockpiles.
🤝 In 2024, Sabin partnered with @KEMRI_Kenya to optimize the use of the oral cholera vaccine, informing strategies aimed at tackling the global resurgence as well as acute vaccine shortages.
💧 This #WorldWaterDay, learn more about cholera and the increased risk of waterborne disease that comes with insufficient water, sanitation, and hygiene (#WASH) infrastructure.
https://t.co/PdLVdG2qNH
At NextGen Lawyers, we're all about pushing boundaries in research & innovation. Our ED @KatindiMelba will be moderating an exciting session on elevating research standards, including a session on strengthening community systems during the 15th KASH conference.
@KEMRI_Kenya
The 15th KEMRI Annual Scientific & Health Conference kicked off today in Nairobi, themed "Research, Technology, and Innovation for a Sustainable Health System."
The event highlights the importance of evidence-based solutions, technology, and innovation in strengthening Kenya’s healthcare sector.
Discussions will cover digital health, emerging diseases, and AI in medical research, aiming to foster collaborations and drive progress in public health.
#KEMRI #HealthInnovation #SustainableHealthcare
We are excited to be part of the ongoing #KASHconference. The conference was officially opened by @psmuthoni,who emphasized the critical role of research, technology, and innovation in creating sustainable and community-driven health systems. #KASH2025
We are excited to announce our new research partnership with @KEMRI_Kenya funded by @wellcometrust to optimize oral #cholera vaccine dosing & intervals between doses. The goal is to help with global outbreaks and alleviate acute vaccine shortages.
https://t.co/CKtctngY89
@MichaelLusiola, CEO- @BioVaxInstitute, participated in the KASH 2024 Conference at @KEMRI_Kenya. The main theme for the conference is " Harnessing Biomedical Research Innovations and Big Data for Health System Resilience, Local Manufacturing, and Commercialization".
#KASH2024
Celebrating KEMRI's achievements, Health CS Nakhumicha lauded the Kemri’s recognition as Kenya's premier health research institution and its global impact through groundbreaking studies. Notably, the recommendation by the World Health Organization for the use of the RTS, S/AS01 malaria vaccine underscores KEMRI's commitment to excellence in research and its contribution to combating pressing health challenges.
𝐂𝐚𝐛𝐢𝐧𝐞𝐭 𝐒𝐞𝐜𝐫𝐞𝐭𝐚𝐫𝐲 𝐍𝐚𝐤𝐡𝐮𝐦𝐢𝐜𝐡𝐚 𝐔𝐫𝐠𝐞𝐬 𝐀𝐜𝐭𝐢𝐨𝐧 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐚𝐭 𝟏𝟒𝐭𝐡 𝐊𝐄𝐌𝐑𝐈 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞
The Cabinet Secretary of the Ministry of Health, Nakhumicha S. Wafula, has emphasized the urgent need to address critical healthcare challenges through innovative solutions and collaborative efforts.
Speaking during the opening of the 14th Kenya Medical Research Institute (KEMRI) Annual Scientific and Health (KASH) Conference in Nairobi today, the CS highlighted the imperative to translate research outcomes into tangible health products to benefit communities effectively.
Under the conference theme, "Harnessing Biomedical Research Innovations & Big Data for Health System Resilience, Local Manufacturing, & Commercialization," the conference marks a significant milestone in advancing healthcare innovation and research across the region, and focuses on regional biopharmaceutical and medtech innovation, echoing the CS call to action.
We're participating in the KASH Conference hosted by @KEMRI_Kenya!
@RobertMuhia1 & Eng. Wambui Nyabero will be participating in panels about biopharmaceutical innovation & medtech innovation!
Register today to join us at @SafariPark_H 14-16 Feb: https://t.co/7WEbrg2aZt
Join me as I live tweet from the 2023 Global #OneHealth Symposium in Nairobi with @KEMRI_Kenya@OSUGlobal and other important partners - 2 full days of talks, shared learning, and connecting with colleagues new and established in celebration of #OneHealthDay